1TUR-KASPA R,LAUB O.Corticosteroids stimulate hepatitis B virus DNA,mRNA and protein production in a stable expression system[J].J Hepatol,1990,11:34-36.
2KANDA Y,SHIGENO K,KINOSHITA N.Sudden hearing loss associated with interferon[J].Lancet,1994,343:1134-1135.
1Patrick DM, Buxton JA, Bigham M, Mathias RG. Public health and hepatitis C. Can J Public Health 2000; 91(Suppl 1): S18-23.
2McHuichison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Jak C, Garaud JJ, Albrecht JK. International Hepatitis Interventional Therapy Group. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123:1061-1069.
3Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht T. Randomized trial of interferon alpha2b plus ribavirin for 48 wk or for 24 wk versus interferon alpha 2b plus placebo for 48 wk for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).Lancet 1998; 352:1426-1432.
4McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-1492.
5Manns MP,McHutchison JG,Gordon SC,Rustgi VK,Shiffman M,Reindollar R,Goodman JG,Koury K,Ling M,Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.Lancet 2001;358:958-965.
6Fried MW, Schiffman ML, Reddy KR, Smith C, Marinos G,Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-982.
7Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M,Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D,Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. PEGASYS International Study Group. Ann Intern Med 2004; 140:346-355.
8Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Welled O. Randomized, double-blind, placebo-controlled trial of interferon alpha-2-b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351:83-87.
9Formann E, Stauber R, Denk DM,Jessner W, Zollner G, Munda-Seinedl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004; 99:873-877.
10Obrebowski A, Walczak M, Swidzinski P, Karlik M,Kurywczak-Grykiel K, Obrebowska-Karsznia Z. Otolarngol Pol 2003: 57:531-555.
